External Nitric Oxide Measurement Through SNO Degradation
Launched by INDIANA UNIVERSITY · May 25, 2021
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
S-nitrosylation is the covalent attachment of a nitric oxide group to cystine thiol within a protein to form an S-nitrosothiol (SNO); it has diverse regulatory roles in all mammalian cells and thus operates as a fundamental mechanism for cellular signaling and accounts for a large part of nitric oxide activity. Though SNOs are relevant to many biological disciplines like neuronal, muscular, respiratory, and cardiovascular biology, currently there is no way to measure SNOs that is both easy to use in a clinical setting and accurate in detecting low concentrations; detection is challenging du...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Adult males or females age ≥ 1 day and ≤ 75 years at time of enrollment
- • Exclusion Criteria
- * Subjects meeting the following criteria will be excluded:
- • Smokers.
- • Any chronic skin conditions.
- • Pregnant.
- • Subjects that are unable or unwilling to cooperate with specimen collection.
- • Subjects with diagnosis of any medical condition that in the investigator's opinion would make them unsuitable for study participation.
- • (for subjects ≥ 18) Subjects that lack the capacity to consent for themselves.
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Indianapolis, Indiana, United States
Patients applied
Trial Officials
Nadzeya Marozkina, PhD, MD
Principal Investigator
Indiana University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials